Literature DB >> 7277112

Clindamycin therapy of staphylococcal pulmonary infections in patients with cystic fibrosis.

R M Shapera, W J Warwick, J M Matsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7277112     DOI： 10.1016/s0022-3476(81)80282-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

Review 1.  Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis.

Authors:  K McCaffery; R E Olver; M Franklin; S Mukhopadhyay
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

2.  Eradication of methicillin-resistant Staphylococcus aureus from the lower respiratory tract of patients with cystic fibrosis.

Authors:  D R Burdge; E Nakielna; M Noble
Journal:  Can J Infect Dis       Date:  1995-03

3.  Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.

Authors:  Margaret Rosenfeld; Oli Rayner; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2020-09-30

Review 4.  Oral anti-pseudomonal antibiotics for cystic fibrosis.

Authors:  Tracey Remmington; Nikki Jahnke; Christian Harkensee
Journal:  Cochrane Database Syst Rev       Date:  2016-07-14

Review 5.  Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Authors:  David Kh Lo; Marianne S Muhlebach; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2018-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.